OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Revivo

1 Projects | 1 Researchers | $295,300 Invested

2008

Revivo

Doug Cowart, PhD

Development of a Sustained Release Oral Formulation of sGC 1061, A New Therapeutic Agent for the Treatment of Alzheimer's Disease Related Cognitive Deficiency

  • Funding Amount: $295,300
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed